ResearchMoz: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

Description

ResearchMoz: Asthma TherapeuticsResearchMoz: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth PR Newswire ALBANY, New York, October 10, 2013 New Report Added in ResearchMoz Reports Database Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth ResearchMoz announces that it has published a new study Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Researchmoz presents this most up-to-date Market Research Reports on Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth (http://www.researchmoz.us/asthma-therapeutics-market-to-2019- breakthrough-biologics-to-enhance-treatment-of-severe-asthma-and-drive- market-growth-report.html). The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Asthma Therapeutics Market. A leading business intelligence provider, has released its latest research report "Asthma Market to 2019". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019.

Informations

• Publié par: researchmoz
• Publié le: 10 octobre 2013
• Nombre de lectures: 7
• Langue: English

Extrait

ResearchMoz: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

PR Newswire

ALBANY, New York, October 10, 2013

New Report Added in ResearchMoz Reports Database Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

ResearchMoz announces that it has published a new study Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

Researchmoz presents this most up-to-date Market Research Reports on Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

(http://www.researchmoz.us/asthma-therapeutics-market-to-2019-breakthrough-biologics-to-enhance-treatment-of-severe-asthma-and-drive-market-growth-report.html). The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Asthma Therapeutics Market.

A leading business intelligence provider, has released its latest research report "Asthma Market to 2019". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing the leading brands, and is a consequence of new market entrants and a disease prevalence that continues to rise, albeit not at rates as high as have been seen in the past. Some new, costly asthma therapies could be set to enter the asthma market, including GlaxoSmithKline's (GSK's) recently approved Relvar (fluticasone/vilanterol), and multiple monoclonal antibodies (mAbs). 

These include reslizumab, mepolizumab and lebrikizumab, which are being developed by Teva, GSK and Roche respectively. The mAbs, in particular, have the potential to change the asthma treatment landscape, most notably with regards to severe forms of the disease. Although such therapy may only play the role of an alternative treatment in the asthma treatment algorithm, their ability to reduce exacerbation rates has strong clinical and commercial value.

To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/asthma-therapeutics-market-to-2019-breakthrough-biologics-to-enhance-treatment-of-severe-asthma-and-drive-market-growth-report.html

Scope

The report assesses the current asthma market, and forecasts market trends to 2019, analyzing key drivers and barriers. The areas covered include the following:

A disease introduction, which defines the disease, including symptoms, diagnosis and treatment

Analysis of the landscape of the asthma market, including a comparison of the efficacy and safety of the most prominent brands

Detailed analysis of the asthma pipeline, including, among other parameters, details of drug distribution by phase, molecule type and mechanism of action. The asthma clinical trial landscape is then analyzed, with a particular emphasis on failure rates across phases as well as trends in clinical trial size and duration, and by mechanism of action. This section also includes single-product forecasts for the most promising pipeline drugs.

An in-depth forecasting model for the asthma market, which considers the current marketed therapies, in addition to the potential market entry of new products. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies.

Analysis of strategic consolidations within the asthma indication, including co-development and licensing agreements

An overview of the drivers and barriers for the asthma market

Browse More Report @ http://www.researchmoz.us/therapeutic-area-market-reports-37.html

Reasons to Buy

Primarily, the report will enable clients to establish a strong understanding of the asthma indication, helping to identify and understand market opportunities and the emerging competitive environment. It will also enable you to:

Understand the asthma pipeline and the factors that indicate that it is becoming more innovative. This is highlighted by the presence of numerous biologics in the pipeline, which look set to have a major impact upon the asthma market.

Observe detailed profiles for promising pipeline products, including revenue forecasts, and gain insights into how they are likely to compete in the market and who their main competitors will be.

Follow the trends in asthma clinical trial size and duration in relation to industry averages. In addition, the report will enable you to assess the potential risk of future developmental programs for asthma therapeutics, depending on the mechanism of action, by considering the recorded clinical trial failure rates.

Observe the potential growth patterns expected for the asthma market over the forecast period, and identify which countries are expected to contribute the most to this growth.

Table of Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Disease Introduction
2.2 Symptoms
2.3 Etiology
2.4 Pathophysiology
2.5 Diagnosis
2.6 Assessment of Disease Severity
2.7 Treatment
2.8 Treatment Algorithm

3 Marketed Products
3.1 Product Profiles
3.1.1 Advair Diskus (fluticasone and salmeterol) - GlaxoSmithKline
3.1.2 Symbicort (budesonide/formoterol) - AstraZeneca, Co-promotion with Astellas Pharma Inc
3.1.3 Singulair (montelukast) - Merck & Co
3.1.4 Xolair (omalizumab) - Novartis and Genentech
3.1.5 Foradil (formoterol) - Novartis (Co-marketed by Novartis and Schering Corporation)
3.1.6 Dulera/Zenhale (mometasone/formoterol) - Merck & Co
3.1.7 Relvar/Breo - GlaxoSmithKline/Theravance

4 Asthma Pipeline
4.1 Overview
4.2 Mechanisms of Action in the Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate
4.3.2 Clinical Trial Duration
4.3.3 Clinical Trial Size
4.3.4 Comparative Clinical Trial Metrics Analysis
4.4 Promising Pipeline Molecules
4.4.1 Reslizumab - Teva Pharmaceutical ltd
4.4.2 Mepolizumab - GlaxoSmithKline
4.4.3 Lebrikizumab - Roche/Genentech
4.4.4 Veramyst - GlaxoSmithKline
4.4.5 Andolast - Rottapharm Madaus
4.4.6 Spiriva (Tiotropium Bromide) - Boehringer Ingelheim
4.5 Heat Map of Safety and Efficacy for Pipeline and Marketed Products

5 Market Forecast to 2019
5.1 Geographical Markets
5.1.1 Global Market
5.1.2 North America
5.1.3 Top Five Countries of Europe
5.1.4 Japan
5.2 Drivers and Barriers for the Asthma Therapeutics Market
5.2.1 Drivers
5.2.2 Barriers

6 Strategic Consolidations
6.1 Major Licensing Deals
6.2 Major Co-development Deals

7 Appendix
7.1 All Pipeline Drugs by Phase
7.1.1 Discovery
7.1.2 Preclinical
7.1.3 Phase I
7.1.4 Phase II
7.1.5 Phase III
7.1.6 Filed
7.1.7 Undisclosed
7.2 Market Forecast to 2019
7.2.1 Global
7.2.2 US
7.2.3 Canada
7.2.4 UK
7.2.5 France
7.2.6 Germany
7.2.7 Italy
7.2.8 Spain
7.2.9 Japan
7.3 References
7.3.1 References for Pipeline Heat Map
7.3.2 References for Marketed Heat Map
7.4 Market Definitions
7.5 Abbreviations
7.6 Methodology
7.7 Coverage
7.8 Secondary Research
7.9 Therapeutic Landscape
7.10 Epidemiology-Based Forecasting
7.10.1 Analogous Forecasting Methodology
7.11 Market Size by Geography
7.11.1 Forecasting Model for Therapeutic Areas
7.12 Geographical Landscape
7.13 Pipeline Analysis
7.14 Competitive Landscape
7.14.1 Expert Panel Validation
7.15 Contact Us
7.16 Disclaimer

New Research Reports:

Big Data and Telecom Analytics Market: Big Data refers to a massive volume of both structured and unstructured data that is so large that it is difficult to process using traditional database and software techniques. While the presence of such datasets is not something new, the past few years have witnessed immense commercial investments in solutions that address the processing and analysis of Big Data. Big Data opens a vast array of applications and opportunities in multiple vertical sectors including, but not limited to, retail and hospitality, media, utilities, financial services, healthcare and pharmaceutical, telecommunications, government, homeland security, and the emerging industrial Internet vertical. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/big-data-and-telecom-analytics-market-business-case-market-analysis-and-forecasts-2014-2019-report.html

Mammography Equipment Market to 2019